Reference drugs for triple combination test drug in Russia [Design Issues]

posted by PharmCat  – Russia, 2019-11-16 17:22  – Posting: # 20812
Views: 1,220

» Generic companies did develop almost all attractive double combinations for cardiovasulcar diseases and were trying to expand to triple combinations.

And all this at the moment is a offense against the law.

Complete thread:

 Admin contact
20,255 posts in 4,263 threads, 1,398 registered users;
online 11 (0 registered, 11 guests [including 7 identified bots]).
Forum time (Europe/Vienna): 11:43 CET

You should treat as many patients as possible with the new drugs
while they still have the power to heal.    Armand Trousseau

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz